Pleasanton, CA, United States of America

Lorin K Johnson

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 2.0

ph-index = 12

Forward Citations = 438(Granted Patents)


Location History:

  • Castro Valley, CA (US) (1986 - 1988)
  • Pleasanton, CA (US) (1988 - 1999)
  • Palo Alto, CA (US) (2008 - 2015)

Company Filing History:


Years Active: 1986-2015

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):

Title: Innovations of Lorin K Johnson: A Pioneer in Pharmaceutical Patents

Introduction

Lorin K Johnson, based in Pleasanton, California, is a notable inventor with an impressive portfolio of 19 patents. His work primarily focuses on enhancing the bioavailability of various pharmaceuticals, particularly in formulations that incorporate specific food administration methods.

Latest Patents

Among his recent advancements are two significant patents related to the formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives. The first patent details a method for increasing the bioavailability of balsalazide when administered with food. This method includes an oral dosage form of balsalazide contained in a suitable package alongside printed labeling that highlights the increased effectiveness of the medication when consumed with food.

The second patent mirrors the first in structure but shifts focus to the 5-aminosalicylate compound, providing a similar method of increasing its bioavailability through oral dosage forms taken with food. This consistency in approach underscores Johnson’s commitment to optimizing pharmaceutical efficacy.

Career Highlights

Lorin K Johnson has contributed significantly to the pharmaceutical sector, with his experience spanning essential roles at reputable companies such as Salix Pharmaceuticals, Inc. and Biotechnology Research Associates, Inc. His innovations have not only advanced product formulations but also improved patient outcomes in medication.

Collaborations

Throughout his career, Johnson has collaborated with noted professionals in his field, including John A Lewicki and John P Longenecker. These partnerships reflect his ability to work within teams, further driving innovation in pharmaceutical research and development.

Conclusion

Lorin K Johnson stands out as a key figure in the realm of pharmaceutical inventions, especially concerning the bioavailability of critical medications. His 19 patents and collaboration with leading professionals mark him as a significant contributor to advancements in drug formulation and delivery methods. As innovations in this sector continue to evolve, Johnson’s work remains influential and invaluable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…